ArticleJournal of medical case reports2025
Acute ST elevation myocardial infarction in a young female patient without cardiovascular risk factors-Massive left main coronary artery thrombosis induced by oral contraceptive pills: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe association between oral contraceptive pills and cardiovascular events, including myocardial infarction, has been a subject of debate in the medical literature. While previous studies have suggested a potential link between estrogen-containing contraceptives and an increased risk of thrombotic events, the absolute risk remains low, particularly in young, healthy women without underlying cardiovascular risk factors. CASE PRESENTATION: We report a rare case of a 32-year-old healthy Lebanese female patient with no significant past medical history or cardiovascular risk factors who developed acute coronary syndrome due to coronary artery thrombosis 8 months after initiating oral contraceptive pills (Yasmin tablets; 3.0 mg drospirenone and 0.030 mg ethinyl estradiol).
conclusionThis case highlights the need for heightened vigilance and awareness of the potential arterial thrombosis risk associated with oral contraceptive pill use, especially in young women with no other cardiovascular risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.